Exercise-induced natriuretic peptide secretion predicts cardioversion outcome in patients with persistent atrial fibrillation: Discordant ANP and B-type natriuretic peptide response to exercise testing

PACE - Pacing and Clinical Electrophysiology

Volumn 33, Issue 10, 2010, Pages 1203-1209

  Wozakowska Kaplon, Beata ^a,b   Opolski, Grzegorz ^c  

^a Swietokrzyskie Centre of Cardiology   (Poland)

^b University of Humanities and Science   (Poland)

^c MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

atrial fibrillation; cardioversion; natriuretic peptides; prognosis

Indexed keywords

ATRIAL NATRIURETIC FACTOR; NATRIURETIC FACTOR; NATRIURETIC FACTOR B TYPE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CARDIOVERSION; EXERCISE; EXERCISE TEST; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE FUNCTION; HUMAN; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PROTEIN SECRETION; SINUS RHYTHM; TREADMILL EXERCISE;

ADULT; AGED; ATRIAL FIBRILLATION; ATRIAL NATRIURETIC FACTOR; CHRONIC DISEASE; CORONARY SINUS; ELECTRIC COUNTERSHOCK; EXERCISE TEST; HUMANS; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PROGNOSIS; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 77957367407     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2010.02789.x     Document Type: Article

References (31)

1. De Denus S, Sanoski CA, Carlsson J, Opolski G, Spinler SA. Rate versus rhythm control in patients with atrial fibrillation. A meta-analysis. Arch Intern Med 2005 165 : 258 262.
2. Hagens VE, Vermeulen KM, TenVergert EM, Van Veldhuisen DJ, Bosker HA, Kamp O, Kingma JH, et al. RACE study group. Rate control is more costeffective than rhythm control for patients with persistent atrial fibrillation - results from the Rate Control versus Electrical Cardioversion (RACE) study. Eur Heart J 2004 25 : 1542 1549. (Pubitemid 39165633)
3. Corley SD, Epstein AE, DiMarco JP. AFFIRM Investigators. Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Circulation 2004 109 : 1509 1513.
4. Daniels LB, Maisel AS. Natriuretic peptides. J Am Coll Cardiol 2007 50 : 2357 2368.
5. Wożakowska-Kapłon B, Opolski G. Effects of exercise testing on natriuretic peptide secretion in patients with atrial fibrillation. Kardiol Pol 2009 67 : 254 261.
6. Gibbons RJ, Balady GJ, Beasley JW, Bricker JT, Duvernoy WF, Froelicher VF, Mark DB, et al. ACC/AHA guidelines for exercise testing: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). J Am Coll Cardiol 1997 30 : 260 272.
7. Atwood JE, Myers J. Exercise hemodynamics of atrial fibrillation. In : Falk RH, Podrid PJ (eds. Atrial Fibrillation. Mechanisms and Management. 2nd Ed. Philadelphia, Lippincott-Raven Publishers, 1997, pp. 219 239.
8. Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation). Eur Heart J 2006 27 : 1979 2030. (Pubitemid 44313588)
9. Wozakowska-Kaplon B, Opolski G. The dubious value of echocardiographic and plasma ANP measurements in predicting outcome of cardioversion in patients with persistent atrial fibrillation. Int J Cardiol 2005 193 : 280 285.
10. Wozakowska-Kaplon B, Opolski G, Kosior D, Janion M. An increase in plasma atrial natriuretic peptide concentration during exercise predicts a successful cardioversion and maintenance of sinus rhythm in patients with chronic atrial fibrillation. Pacing Clin Electrophysiol 2000 23 : 1876 1879.
11. Van Den Berg MP, Tjeerdsma G, Jan de Kam P, Boomsma F, Crijns HJ, van Veldhuisen DJ. Longstanding atrial fibrillation causes depletion of atrial natriuretic peptide in patients with advanced congestive heart failure. Eur J Heart Fail 2002 4 : 255 262.
12. Wozakowska-Kaplon B, Opolski G, Janion M, Kosior D. Plasma concentration of atrial natriuretic peptide is related to the duration of atrial fibrillation in patients with advanced heart failure. Kardiol Pol 2004 61 : 513 517.
13. Thijssen VL, Ausma J, Liu GS, Allessie MA, van Eys GJ, Borgers M. Structural changes of atrial myocardium during chronic atrial fibrillation. Cardiovasc Pathol 2000 9 : 17 28.
14. Röcken C, Peters B, Juenemann G, Saeger W, Klein HU, Huth C, Roessner A, et al. Atrial amyloidosis: An arrhythmogenic substrate for persistent atrial fibrillation. Circulation 2002 106 : 2091 2097.
15. Yoshihara F, Nishikimi T, Sasako Y, Hino J, Kobayashi J, Minatoya K, Bando K, et al. Plasma atrial natriuretic peptide concentration inversely correlates with left atrial collagen volume fraction in patients with atrial fibrillation. Plasma ANP as a possible biochemical marker to predict the outcome of the Maze procedure. J Am Coll Cardiol 2002 39 : 288 294.
16. Yamada T, Fukunami M, Shimonagata T, Kumagai K, Ogita H, Asano Y, Hirata A, et al. Prediction of paroxysmal atrial fibrillation in patients with congestive heart failure: A prospective study. J Am Coll Cardiol 2000 35 : 405 413. (Pubitemid 30125532)
17. Larsen AI, Hall C, Aukrust P, Aarsland T, Faris P, Dickstein K. Prognostic usefulness of an increase of N-terminal proatrial natriuretic peptide during exercise in patients with chronic heart failure. Am J Cardiol 2003 92 : 91 94.
18. Engelmann MD, Niemann L, Kanstrup IL, Skagen K, Godtfredsen J. Natriuretic peptide response to dynamic exercise in patients with atrial fibrillation. Int J Cardiol 2005 105 : 31 39.
19. Van Den Berg MP, van Veldhuisen DJ. Atrial natriuretic peptide in atrial fibrillation: A protective but time-limited system. Int J Cardiol 2002 83 : 207 208.
20. Möllmann H, Weber M, Elsässer A, Nef H, Dill T, Rixe J, Schmitt J, et al. NT-ProBNP predicts rhythm stability after cardioversion of lone atrial fibrillation. Circ J 2008 72 : 921 925.
21. Beck-da-Silva L, de Bold A, Fraser M, Williams K, Haddad H. Brain natriuretic peptide predicts successful cardioversion in patients with atrial fibrillation and maintenance of sinus rhythm. Can J Cardiol 2004 20 : 1245 1248.
22. Danicek V, Theodorovich N, Bar-Chaim S, Miller A, Vered Z, Koren-Morag N, Uriel N, et al. Sinus rhythm restoration after atrial fibrillation: The clinical value of N-terminal pro-BNP measurements. Pacing Clin Electrophysiol 2008 31 : 955 960.
23. Wozakowska-Kapłon B. ANP and B-type peptide: Twins or kins? Different predictive value in atrial fibrillation. Int J Cardiol 2009 : in press.
24. Wazni OM, Martin DO, Marrouche NF, Latif AA, Ziada K, Shaaraoui M, Almahameed S, et al. Plasma B-type natriuretic peptide levels predict postoperative atrial fibrillation in patients undergoing cardiac surgery. Circulation 2004 110 : 124 127.
25. Wozakowska-Kaplon B. Effects of sinus rhythm restoration on plasma brain natriuretic peptide in patients with atrial fibrillation. Am J Cardiol 2004 93 : 1555 1558. (Pubitemid 38749221)
26. Sacher F, Corcuff JB, Schraub P, Le Bouffos V, Georges A, Jones SO, Lafitte S, et al. Chronic atrial fibrillation ablation impact on endocrine and mechanical cardiac functions. Eur Heart J 2008 29 : 1290 1295.
27. Mabuchi N, Tsutamoto T, Maeda K, Kinoshita M. Plasma cardiac natriuretic peptides as biochemical markers of recurrence of atrial fibrillation in patients with congestive heart failure. Jpn Circ J 2000 64 : 765 771.
28. Horie H, Tsutamoto T, Minai K, Hayashi M, Kito O, Kinoshita M. Brain natriuretic peptide predicts chronic atrial fibrillation after ventricular pacing in patients with sick sinus syndrome. Jpn Circ J 2000 64 : 965 970.
29. Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Omland T, Wolf PA, et al. Plasma natriuretic peptide levels at risk of cardiovascular events and death. N Engl J Med 2004 350 : 655 663.
30. Yoshimura M, Yasue H, Okumura K. Different secretion patterns of atrial and brain natriuretic peptide in patients with congestive heart failure. Circulation 1993 87 : 464 469.
31. Ellinor PT, Low AF, Patton KK, Shea MA, Macrae CA. Discordant atrial natriuretic peptide and brain natriuretic levels in lone atrial fibrillation. J Am Coll Cardiol 2005 45 : 82 86.